Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A

[1]  T. Greenough,et al.  What’s new in the renin-angiotensin system? , 2004, Cellular and Molecular Life Sciences CMLS.

[2]  A. Velázquez‐Campoy,et al.  Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro. , 2004, Biochemistry.

[3]  Andreas Koeller,et al.  Sabadinine: a potential non-peptide anti-severe acute-respiratory-syndrome agent identified using structure-aided design. , 2004, Journal of medicinal chemistry.

[4]  Xiaolei Yin,et al.  Expression cloning of functional receptor used by SARS coronavirus , 2004, Biochemical and Biophysical Research Communications.

[5]  G. Gao,et al.  The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Rodrigo Lopez,et al.  Multiple sequence alignment with the Clustal series of programs , 2003, Nucleic Acids Res..

[7]  H. Doerr,et al.  Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus , 2003, The Lancet.

[8]  Rolf Hilgenfeld,et al.  Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs , 2003, Science.

[9]  Leszek Rychlewski,et al.  mRNA Cap-1 Methyltransferase in the SARS Genome , 2003, Cell.

[10]  Yuan WANG,et al.  Identification of an epitope of SARS-coronavirus nucleocapsid protein , 2003, Cell Research.

[11]  Jing Chen,et al.  Small envelope protein E of SARS: cloning, expression, purification, CD determination, and bioinformatics analysis. , 2003, Acta pharmacologica Sinica.

[12]  Cheng Luo,et al.  A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening. , 2003, Acta pharmacologica Sinica.

[13]  W. Sundquist,et al.  Structural insights into the catalytic mechanism of cyclophilin A , 2003, Nature Structural Biology.

[14]  Christian Drosten,et al.  Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.

[15]  Obi L. Griffith,et al.  The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.

[16]  J. Peiris,et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study , 2003, The Lancet.

[17]  Christian Drosten,et al.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[18]  Arthur S Slutsky,et al.  Identification of severe acute respiratory syndrome in Canada. , 2003, The New England journal of medicine.

[19]  Peter Cameron,et al.  A major outbreak of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.

[20]  J. A. Comer,et al.  A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[21]  K. Yuen,et al.  A cluster of cases of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.

[22]  Krishna Shankara Narayanan,et al.  Nucleocapsid-Independent Specific Viral RNA Packaging via Viral Envelope Protein and Viral RNA Signal , 2003, Journal of Virology.

[23]  L. Nilsson,et al.  Structure and Dynamics of the TIP3P, SPC, and SPC/E Water Models at 298 K , 2001 .

[24]  J. Sühnel,et al.  C-h⋯π-interactions in proteins , 2001 .

[25]  J. Luban,et al.  Cyclophilin A regulates HIV‐1 infectivity, as demonstrated by gene targeting in human T cells , 2001, The EMBO journal.

[26]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[27]  P. Kollman,et al.  Binding of a diverse set of ligands to avidin and streptavidin: an accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models. , 2000, Journal of medicinal chemistry.

[28]  Krishna Shankara Narayanan,et al.  Characterization of the Coronavirus M Protein and Nucleocapsid Interaction in Infected Cells , 2000, Journal of Virology.

[29]  D. A. Dougherty,et al.  Cation-π interactions in structural biology , 1999 .

[30]  W. Sundquist,et al.  Molecular recognition in the HIV-1 capsid/cyclophilin A complex. , 1997, Journal of molecular biology.

[31]  R M Esnouf,et al.  An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. , 1997, Journal of molecular graphics & modelling.

[32]  S. Moyer,et al.  An amino-terminal domain of the Sendai virus nucleocapsid protein is required for template function in viral RNA synthesis , 1997, Journal of virology.

[33]  W. Sundquist,et al.  Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid , 1996, Cell.

[34]  J. Tözsér,et al.  Effect of cyclosporin A on the replication cycle of human immunodeficiency virus type 1 derived from H9 and Molt-4 producer cells. , 1996, The Journal of general virology.

[35]  Michael R. Green,et al.  A human nucleoporin-like protein that specifically interacts with HIV Rev , 1995, Nature.

[36]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[37]  Jeremy Luban,et al.  Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B , 1993, Cell.

[38]  M. Lowdell,et al.  Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Wainberg,et al.  The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1. , 1988, Blood.

[40]  D. Speicher,et al.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A. , 1984, Science.

[41]  ChenJing,et al.  Small envelope protein E of SARS：cloning,expression, purification, CD determination, and bioinformatics analysis , 2003 .

[42]  Ioannis Xenarios,et al.  DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions , 2002, Nucleic Acids Res..

[43]  D. A. Dougherty,et al.  Cation-pi interactions in structural biology. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  B. Hogue.  Bovine coronavirus nucleocapsid protein processing and assembly. , 1995, Advances in experimental medicine and biology.

[45]  K. Sharp,et al.  Electrostatic interactions in macromolecules: theory and applications. , 1990, Annual review of biophysics and biophysical chemistry.

[46]  J Sühnel,et al.  More Hydrogen Bonds for the (structural) Biologist , 2022 .